Skip to main content
. 2020 Mar 19;35(11):1878–1885. doi: 10.1093/ndt/gfaa029

Table 3.

HR of incident PAD by eGFR, Visit 2

eGFR ≥60
eGFR <60
P-for-interaction
N
11 606
233
Events
436
35
Variable HR (95% CI) P-value HR (95% CI) P-value
 Higher calciuma 1.06 (0.86–1.29) 0.60 0.68 (0.31–1.48) 0.33 0.17
 Higher phosphorusa 1.01 (0.83–1.24) 0.90 1.22 (0.53–2.78) 0.64 0.95
 Higher iPTHa 1.07 (0.88–1.30) 0.52 0.51 (0.22–1.22) 0.13 0.93
 Higher FGF-23a 1.09 (0.90–1.32) 0.39 1.40 (0.42–4.73) 0.58 0.84
 Higher calciumb 0.59 (0.33–1.07) 0.08 2.10 (0.44–9.97) 0.35 0.43
 Higher phosphorusb 2.01 (1.36–2.95) <0.001 1.87 (0.64–5.49) 0.25 0.82
 Higher iPTHb 1.09 (0.76–1.55) 0.64 2.24 (0.94–5.36) 0.07 0.01
 Higher FGF-23b 1.43 (1.10–1.86) 0.01 0.94 (0.37–2.39) 0.90 0.60

Adjusted for age, sex, race, education, smoking status, drinking status, hypertension, diabetes mellitus, prevalent coronary heart disease, total cholesterol and HDL cholesterol.

a

Calcium, phosphorus, iPTH and FGF-23 above versus below their median values.

b

Calcium, phosphorus, iPTH and FGF-23, above versus below clinical cut-points.